Antiemetics Market Size, Share, Growth & Industry Analysis, By Drug (Serotonin-receptor Antagonists, Glucocorticoids, Anticholinergics, NK-receptor Antagonists & Other), By Application (Chemotherapy, Gastroenteritis, Post-Operative Surgery, Others), By Sales Channel (Retail Pharmacy, Hospital Pharmacy, Online Retail), By Form, and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL ANTIEMETICS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL ANTIEMETICS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL ANTIEMETICS MARKET, BY DRUG
6.1 Overview
6.2 Serotonin-receptor Antagonists
6.3 Glucocorticoids
6.4 Anticholinergics
6.5 NK-receptor Antagonists (Substance-P)
6.6 Dopamine Receptor Antagonists
6.7 Cannabinoids
6.8 Antihistamines
6.9 Other

7 GLOBAL ANTIEMETICS MARKET, BY APPLICATION
7.1 Overview
7.2 Chemotherapy
7.3 Gastroenteritis
7.4 Post-Operative Surgery
7.5 Others

8 GLOBAL ANTIEMETICS MARKET, BY SALES CHANNEL
8.1 Overview
8.2 Retail Pharmacy 
8.3 Hospital Pharmacy 
8.4 Online Retail 

9 GLOBAL ANTIEMETICS MARKET, BY FORM
9.1 Overview
9.2 Capsule & Tablets
9.3 Powder
9.4 Oral Liquid

10 GLOBAL ANTIEMETICS MARKET, BY GEOGRAPHY
10.1 Overview

11 NORTH AMERICA 
11.1 U.S.
11.2 Canada
11.3 Mexico

12 EUROPE 
12.1 Germany
12.2 U.K.
12.3 France
12.4 Italy
12.5 Spain
12.6 Russia
12.7 Rest of Europe

13 ASIA-PACIFIC 
13.1 China
13.2 Japan
13.3 India
13.4 South Korea
13.5 Rest of Asia-Pacific

14 MIDDLE EAST & AFRICA 
14.1 GCC
14.2 South Africa
14.3 North Africa
14.4 Rest of Middle East & Africa

15 LATIN AMERICA 
15.1 Brazil
15.2 Argentina
15.3 Rest of South America

16 GLOBAL ANTIEMETICS MARKET COMPETITIVE LANDSCAPE
16.1 Overview
16.2 Key Developments
16.3 Key Strategic Developments
16.4 Company Market Ranking
16.5 Regional Footprint
16.6 Industry Footprint

17 COMPANY PROFILES
17.1 Pfizer Inc.
17.1.1 Key Facts
17.1.2 Financial Overview
17.1.3 Product Benchmarking
17.1.4 Recent Developments
17.1.5 Winning Imperatives
17.1.6 Current Focus & Strategies
17.1.7 Threat from competition
17.1.8 SWOT Analysis
17.2 Cipla Inc.
17.2.1 Key Facts
17.2.2 Financial Overview
17.2.3 Product Benchmarking
17.2.4 Recent Developments
17.2.5 Winning Imperatives
17.2.6 Current Focus & Strategies
17.2.7 Threat from competition
17.2.8 SWOT Analysis
17.3 Merck KGaA
17.3.1 Key Facts
17.3.2 Financial Overview
17.3.3 Product Benchmarking
17.3.4 Recent Developments
17.3.5 Winning Imperatives
17.3.6 Current Focus & Strategies
17.3.7 Threat from competition
17.3.8 SWOT Analysis
17.4 Eagle Pharmaceuticals, Inc.
17.4.1 Key Facts
17.4.2 Financial Overview
17.4.3 Product Benchmarking
17.4.4 Recent Developments
17.4.5 Winning Imperatives
17.4.6 Current Focus & Strategies
17.4.7 Threat from competition
17.4.8 SWOT Analysis
17.5 Johnson & Johnson Services, Inc.
17.5.1 Key Facts
17.5.2 Financial Overview
17.5.3 Product Benchmarking
17.5.4 Recent Developments
17.5.5 Winning Imperatives
17.5.6 Current Focus & Strategies
17.5.7 Threat from competition
17.5.8 SWOT Analysis
17.6 GlaxoSmithKline plc
17.6.1 Key Facts
17.6.2 Financial Overview
17.6.3 Product Benchmarking
17.6.4 Recent Developments
17.6.5 Winning Imperatives
17.6.6 Current Focus & Strategies
17.6.7 Threat from competition
17.6.8 SWOT Analysis
17.7 Astellas Pharma Inc.
17.7.1 Key Facts
17.7.2 Financial Overview
17.7.3 Product Benchmarking
17.7.4 Recent Developments
17.7.5 Winning Imperatives
17.7.6 Current Focus & Strategies
17.7.7 Threat from competition
17.7.8 SWOT Analysis
17.8 GLENMARK PHARMACEUTICALS LTD.
17.8.1 Key Facts
17.8.2 Financial Overview
17.8.3 Product Benchmarking
17.8.4 Recent Developments
17.8.5 Winning Imperatives
17.8.6 Current Focus & Strategies
17.8.7 Threat from competition
17.8.8 SWOT Analysis
17.9 Viatris Inc.
17.9.1 Key Facts
17.9.2 Financial Overview
17.9.3 Product Benchmarking
17.9.4 Recent Developments
17.9.5 Winning Imperatives
17.9.6 Current Focus & Strategies
17.9.7 Threat from competition
17.9.8 SWOT Analysis
17.10 Baxter
17.10.1 Key Facts
17.10.2 Financial Overview
17.10.3 Product Benchmarking
17.10.4 Recent Developments
17.10.5 Winning Imperatives
17.10.6 Current Focus & Strategies
17.10.7 Threat from competition
17.10.8 SWOT Analysis

LIST OF TABLES

TABLE 1 Global Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 2 Global Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 3 Global Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 4 Global Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 5 Global Antiemetics Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 6 North America Antiemetics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 7 North America Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 8 North America Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 9 North America Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 10 North America Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 11 US Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 12 US Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 13 US Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 14 US Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 15 Canada Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 16 Canada Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 17 Canada Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 18 Canada Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 19 Mexico Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 20 Mexico Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 21 Mexico Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 22 Mexico Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 23 Europe Antiemetics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 24 Europe Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 25 Europe Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 26 Europe Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 27 Europe Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 28 Germany Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 29 Germany Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 30 Germany Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 31 Germany Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 32 France Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 33 France Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 34 France Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 35 France Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 36 U.K. Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 37 U.K. Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 38 U.K. Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 39 U.K. Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 40 Spain Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 41 Spain Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 42 Spain Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 43 Spain Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 44 Italy Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 45 Italy Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 46 Italy Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 47 Italy Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 48 Russia Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 49 Russia Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 50 Russia Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 51 Russia Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 52 Rest of Europe Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 53 Rest of Europe Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 54 Rest of Europe Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 55 Rest of Europe Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 56 Asia-Pacific Antiemetics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 57 Asia-Pacific Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 58 Asia-Pacific Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 59 Asia-Pacific Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 60 Asia-Pacific Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 61 China Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 62 China Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 63 China Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 64 China Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 65 Japan Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 66 Japan Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 67 Japan Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 68 Japan Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 69 India Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 70 India Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 71 India Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 72 India Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 73 South Korea Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 74 South Korea Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 75 South Korea Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 76 South Korea Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 77 Rest of Asia-Pacific Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 78 Rest of Asia-Pacific Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 79 Rest of Asia-Pacific Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 80 Rest of Asia-Pacific Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 81 Middle East and Africa Antiemetics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 82 Middle East and Africa Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 83 Middle East and Africa Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 84 Middle East and Africa Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 85 Middle East and Africa Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 86 GCC Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 87 GCC Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 88 GCC Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 89 GCC Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 90 North Africa Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 91 North Africa Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 92 North Africa Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 93 North Africa Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 94 South Africa Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 95 South Africa Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 96 South Africa Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 97 South Africa Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 98 Rest of Middle East & Africa Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 99 Rest of Middle East & Africa Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 100 Rest of Middle East & Africa Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 101 Rest of Middle East & Africa Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 102 Latin America Antiemetics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 103 Latin America Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 104 Latin America Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 105 Latin America Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 106 Latin America Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 107 Brazil Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 108 Brazil Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 109 Brazil Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 110 Brazil Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 111 Argentina Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 112 Argentina Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 113 Argentina Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 114 Argentina Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 115 Rest of Latin America Antiemetics Market Revenue, By Drug, 2021 – 2031 (USD Billion)
TABLE 116 Rest of Latin America Antiemetics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 117 Rest of Latin America Antiemetics Market Revenue, By Sales Channel, 2021 – 2031 (USD Billion)
TABLE 118 Rest of Latin America Antiemetics Market Revenue, By Form, 2021 – 2031 (USD Billion)
TABLE 119 Company Market Ranking
TABLE 120 Regional Footprint
TABLE 121 Product Benchmarking
TABLE 122 Recent Developments
TABLE 123 Winning Imperatives 

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Antiemetics Market 2021-2031 (USD Billion)
FIG. 4 Global Antiemetics Market Geographical Analysis (CAGR %)
FIG. 5 Global Antiemetics Absolute Market Opportunity (USD Billion)
FIG. 6 Global Antiemetics Market Attractiveness (USD Billion)
FIG. 7 Global Antiemetics Market, By Drug, 2021-2031 (USD Billion)
FIG. 8 Global Antiemetics Market, By Application, 2021-2031 (USD Billion)
FIG. 9 Global Antiemetics Market, By Sales Channel, 2021-2031 (USD Billion)
FIG. 10 Global Antiemetics Market, By Form, 2021-2031 (USD Billion)
FIG. 11 Research Methodology
FIG. 12 Research Process
FIG. 13 Bottom-Up Approach
FIG. 14 Top-Bottom Approach
FIG. 15 Market Dynamics Overview
FIG. 16 Porter's Five Forces Analysis
FIG. 17 Value Chain Analysis
FIG. 18 Macroeconomic Analysis
FIG. 19 Global Antiemetics Market Revenue Share, By Drug, 2023 and 2031 (%)
FIG. 20 Global Antiemetics Market Revenue Share, By Application, 2023 and 2031 (%)
FIG. 21 Global Antiemetics Market Revenue Share, By Sales Channel, 2023 and 2031 (%)
FIG. 22 Global Antiemetics Market Revenue Share, By Form, 2023 and 2031 (%)
FIG. 23 Global Antiemetics Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 25 North America Antiemetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 27 Europe Antiemetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 29 Asia-Pacific Antiemetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 31 Middle East & Africa Antiemetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 33 Latin America Antiemetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 34 Key Strategic Development
FIG. 35 Key Facts
FIG. 36 Financial Overview
FIG. 37 SWOT Analysis